EyePoint Pharmaceuticals, Inc. provided revenue guidance for the fourth quarter and full year 2022. For the quarter, the company net product revenue estimated to exceed $9.5 million.
For the full-year 2022, the company net product revenue estimated to exceed $39.5 million versus $35.3 million in 2021.